Martin Shkreli, the obscene prankster of biotech, makes his final exit at KaloBios
Martin Shkreli is about as far as you can get from a likeable company representative. So we can only imagine the sigh of relief at KaloBios now that the bad boy of biotech has cashed out of his shares and will now be seen and heard of no more at the company he dragged into the spotlight.
In an SEC filing out Monday morning, Shkreli revealed that he no longer owns any stock in KaloBios, leaving CEO Cameron Durrant free and clear to run the company on a completely different set of ethics around product development and pricing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.